Correlation Between IShares Nasdaq and IShares SP

Can any of the company-specific risk be diversified away by investing in both IShares Nasdaq and IShares SP at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining IShares Nasdaq and IShares SP into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between iShares Nasdaq Biotechnology and iShares SP SmallCap, you can compare the effects of market volatilities on IShares Nasdaq and IShares SP and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in IShares Nasdaq with a short position of IShares SP. Check out your portfolio center. Please also check ongoing floating volatility patterns of IShares Nasdaq and IShares SP.

Diversification Opportunities for IShares Nasdaq and IShares SP

-0.17

Correlation Coefficient

IShares Nasdaq  IShares SP

Good diversification

The 3 months correlation between IShares and IShares is -0.17. Overlapping area represents the amount of risk that can be diversified away by holding iShares Nasdaq Biotechnology and iShares SP SmallCap in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on iShares SP SmallCap and IShares Nasdaq is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on iShares Nasdaq Biotechnology are associated (or correlated) with IShares SP. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of iShares SP SmallCap has no effect on the direction of IShares Nasdaq i.e., IShares Nasdaq and IShares SP go up and down completely randomly.

Pair Corralation between IShares Nasdaq and IShares SP

Assuming the 90 days trading horizon iShares Nasdaq Biotechnology is expected to under-perform the IShares SP. In addition to that, IShares Nasdaq is 1.04 times more volatile than iShares SP SmallCap. It trades about -0.07 of its total potential returns per unit of risk. iShares SP SmallCap is currently generating about 0.03 per unit of volatility. If you would invest  9,300  in iShares SP SmallCap on October 6, 2024 and sell it today you would earn a total of  143.00  from holding iShares SP SmallCap or generate 1.54% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.39%
Values	Daily Returns

iShares Nasdaq Biotechnology  vs.  iShares SP SmallCap

iShares Nasdaq Biote

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days iShares Nasdaq Biotechnology has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest uncertain performance, the Etf's basic indicators remain stable and the newest uproar on Wall Street may also be a sign of mid-term gains for the exchange-traded fund private investors.

iShares SP SmallCap

Risk-Adjusted Performance

1 of 100

Weak

Compared to the overall equity markets, risk-adjusted returns on investments in iShares SP SmallCap are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively stable basic indicators, IShares SP is not utilizing all of its potentials. The newest stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with IShares Nasdaq and IShares SP

The main advantage of trading using opposite IShares Nasdaq and IShares SP positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if IShares Nasdaq position performs unexpectedly, IShares SP can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in IShares SP will offset losses from the drop in IShares SP's long position.

The idea behind iShares Nasdaq Biotechnology and iShares SP SmallCap pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.